Shigellosis
📧 Sign up to get email alerts when something new happens for Shigellosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection [Phase 1, Phase 2]
Phase 1/2 trial exploring dose finding and protection assessment for Shigella flexneri 2a Invaplex 50 vaccine; results completed with posted…
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
This completed clinical trial update reports on diagnosing a range of neglected tropical diseases in patients with persistent digestive diso…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults [Phase 1]
Phase 1 study evaluating a Shigella sonnei vaccine administered by intradermal, intranasal, or intramuscular routes in healthy adults has be…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a [Phase 1]
A Phase 1 study evaluating the safety and tolerability of a bioconjugate vaccine targeting Shigella flexneri 2a has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel [Phase 3]
Phase 3 trial evaluating safety, immunogenicity, and efficacy of Shigella conjugate vaccines in 1-4 year olds in Israel. The study is comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Therapeutic Induction of Endogenous Antibiotics [Phase 2]
Phase 2 clinical trial evaluating induction of endogenous antibiotics for treatment of shigellosis has completed.
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella [Phase 1]
Phase 1 study assessing the safety and reactogenicity of a Shigella bioconjugate vaccine developed by GlycoVaxyn AG.
-
CLINICAL_TRIALS trial_result · 2006-05-03Clinical Trial Update: Zinc Supplementation in Shigella Patients [Phase 3]
A Phase 3 trial evaluating zinc supplementation in patients with Shigella infection has completed.